Eidos Therapeutics Stock Price

-0.16 (-0.39%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Eidos Therapeutics Inc EIDX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-0.16 -0.39% 41.26 40.11 41.59 41.01 41.42 18:00:19
Bid Price Ask Price Spread Spread % News
38.05 45.55 7.50 16.47% 1 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
975 51,606 $ 40.91 $ 2,111,182 70,807 28.39 - 66.5587
Last Trade Time Type Quantity Stock Price Currency
16:45:09 priorref 4,185 $ 41.26 USD

Eidos Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.59B 38.54M 10.98M $ 26.69M $ - -1.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -15.33k 1.20%

more financials information »

Eidos Therapeutics News

Date Time Source News Article
8/07/202016:56Edgar (US Regulatory)Current Report Filing (8-k)
8/07/202016:30GlobeNewswire Inc.Eidos Therapeutics Appoints Industry Leaders With..
8/06/202016:40Edgar (US Regulatory)Quarterly Report (10-q)
8/06/202016:37Edgar (US Regulatory)Current Report Filing (8-k)
8/06/202016:30GlobeNewswire Inc.Eidos Therapeutics Reports Second Quarter 2020 Financial..
8/05/202019:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
7/09/202016:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EIDX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week41.9443.2238.44541.0473,055-0.68-1.62%
1 Month48.8951.9838.44544.7660,315-7.63-15.61%
3 Months39.6153.3838.44546.9485,0411.654.17%
6 Months55.2056.4728.3946.31103,479-13.94-25.25%
1 Year30.2066.558728.3947.36133,93311.0636.62%
3 Years20.0066.55878.8931.82150,64321.26106.3%
5 Years20.0066.55878.8931.82150,64321.26106.3%

Eidos Therapeutics Description

Eidos Therapeutics Inc is a clinical stage biopharmaceutical company focused on addressing the large and growing unmet need in diseases caused by transthyretin, or TTR, amyloidosis, or ATTR. TTR is a protein that occurs naturally in the form of a tetramer and performs multiple beneficial roles, including the transport of essential hormones and vitamins.
Your Recent History
Eidos Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200810 05:20:42